A (H1N1 )virus is not very severe for healthy people
antiviral medicaments are mostly suffisant help
Most people which caught it were not even tested and normaly immune defenses have developed SAME WAY as with a vaccine
The possibillty is poor for rearrangement with virus
A( H5N1 ) at least for next northern hemnisphere flu season
So the biggest risque is a antiviral resistance of A (H1N1 )
I still belive WHO will come up with a mixed polital decision and we will end up with important orders for RELENZA
- Forums
- ASX - By Stock
- BTA
- vaccine or virals
vaccine or virals
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online